Breast Cancer Meeting Highlights - Page 2 - HER2 Support Group Forums

		HER2 Support Group Forums
Breast Cancer Meeting Highlights

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Page 2 of 14

Last »

Threads in Forum : Breast Cancer Meeting Highlights

Forum Tools

Search this Forum

Rating Thread / Thread Starter	Last Post	Replies	Views
Her2 Posters Utilizing VeraTag Assays to be presented at SABCS Hopeful	12-12-2007 02:51 PM by Hopeful	0	2,222
BC patients w/1-3 positive nodes and low risk 70-gene profile have excellent survival Hopeful	12-17-2007 08:23 AM by Hopeful	0	1,428
Her2 Recurrence Rates pre-Herceptin Hopeful	12-16-2007 02:40 PM by Andrea Barnett Budin	9	2,802
Comparison of joint problems as reported by patients in a randomised adjuvant trial Hopeful	12-14-2007 02:43 PM by Hopeful	0	1,790
Impact of ERBB2 on prognosis and microarray data Hopeful	12-14-2007 02:45 PM by Hopeful	0	1,789
The clinical significance of polysomy 17 in the HER2+ N9831 intergroup adjuvant trast Hopeful	12-14-2007 02:48 PM by Hopeful	0	1,738
Mechanism of action of herceptin killing of HER-2+ breast cancer cells under in vitro Hopeful	12-14-2007 02:49 PM by Hopeful	0	1,800
AI's in early breast cancer toxicity and adherence Hopeful	12-14-2007 03:14 PM by Hopeful	0	2,124
Change in annual recurrence rates over the last 10 years - NORA study Hopeful	12-14-2007 03:36 PM by Hopeful	0	2,080
Confirmatory Tissue Biopsy for BC mets strongly recommended Hopeful	12-17-2007 08:25 AM by Hopeful	0	1,354
Multidisciplinary management of menopause symptoms after breast cancer Hopeful	12-17-2007 08:27 AM by Hopeful	0	1,261
For R.B - Her2 and fatty acid synthase in bc cells Hopeful	12-17-2007 08:29 AM by Hopeful	0	1,428
San Antonio Abstracts on line Early Hopeful	12-02-2008 09:42 AM by Hopeful	0	1,268
Determination of HER2 amplification - when should chromosome 17 also be determined Hopeful	12-14-2008 05:55 PM by Becky	2	2,106
BC patients unknowingly dosing themselves with estrogen by using topical moisturizers Hopeful	12-28-2008 01:28 PM by Rich66	9	2,860
A novel breast tissue feature strongly associated with risk of breast cancer Hopeful	12-10-2008 07:30 AM by Hopeful	0	1,877
HER-2 expression on circulating tumor cells in metastatic breast cancer Hopeful	12-10-2008 07:31 AM by Hopeful	0	1,608
Behaviour and metastatic potential of Her2+ and Her2-(CETC) during adjuvant therapy Hopeful	12-10-2008 07:34 AM by Hopeful	0	1,522
Metastatic potential of Her2+ and Her2- CETC released during primary systemic chemo Hopeful	12-11-2008 07:36 AM by Hopeful	0	1,560
Is metabolic syndrome the link between obesity and postmenopausal breast cancer? Hopeful	12-11-2008 07:38 AM by Hopeful	0	1,670
Promoter hypermethylation is an early event in breast carcinogenesis Hopeful	12-11-2008 07:40 AM by Hopeful	0	1,606
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathologica Hopeful	12-11-2008 07:44 AM by Hopeful	0	1,485
Remarkable complete pathologic response rate in Her2+ stage II/III pts in phase II tr Hopeful	12-11-2008 07:47 AM by Hopeful	0	1,808
HER-2/neu expression/amplification is not stable during tumor progression Hopeful	12-12-2008 07:47 AM by Hopeful	0	1,664
PR receptor levels are associated with time to AI treatment failure Hopeful	12-12-2008 07:49 AM by Hopeful	0	1,829
HER2 amplification does not alter outcome in small (1 cm) tumors Hopeful	12-12-2008 07:50 AM by Hopeful	0	1,700
HER2 amplification predicts breast cancer recurrence but not overall survival Hopeful	02-03-2009 09:30 PM by gdpawel	3	2,699
Low penetrance breast cancer predisposition SNPs are site specific Hopeful	12-12-2008 07:52 AM by Hopeful	0	2,167
Pooled cardiac safety analysis of patients with HER2+ MBC receiving trastuzumab Hopeful	12-12-2008 07:54 AM by Hopeful	0	1,763
Chronobiological rhythms of cytokines level of breast cancer Hopeful	03-19-2009 07:00 AM by Hopeful	0	1,874
Presence of an in-situ component is associated with reduced biological aggressiveness Hopeful	03-18-2009 06:17 AM by Hopeful	0	1,711
The coamplification pattern of HER2/NEU amplicon and its clinical significance Hopeful	03-18-2009 06:18 AM by Hopeful	0	1,590
Tumor size vs Her2 amplification in post-meno, ER+ tamoxifen tx pts Hopeful	03-18-2009 06:22 AM by Hopeful	0	1,792
CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcome Hopeful	03-18-2009 06:23 AM by Hopeful	0	1,613
The timing of recurrence after the surgery of breast cancer Hopeful	03-18-2009 06:24 AM by Hopeful	0	1,937
Is there a promotion of metastasis by autologeous breast reconstruction in patients? Hopeful	03-18-2009 06:25 AM by Hopeful	0	1,790
Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiother Hopeful	03-19-2009 06:52 AM by Hopeful	0	1,808
Radiofrequency ablation of early breast cancer followed by delayed surgical resection Hopeful	03-19-2009 06:53 AM by Hopeful	0	1,662
Primary endocrine therapy versus chemo in postmen pts w/ ER+ bc: 5 yr results Hopeful	03-19-2009 07:02 AM by Hopeful	0	1,819
Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer pts Hopeful	03-19-2009 07:04 AM by Hopeful	0	1,910
Combined ER and HER-targeted therapy in breast cancer treatment Hopeful	03-21-2009 10:23 PM by Jackie07	1	2,075
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen Hopeful	05-19-2009 06:32 AM by Hopeful	0	1,652
Treatment of node-negative infra-centimetric HER2+ invasive breast carcinomas Hopeful	05-19-2009 06:33 AM by Hopeful	0	1,555
PIK3CA gene expression signature and prognosis within the luminal-B ER+ bc Hopeful	05-19-2009 06:36 AM by Hopeful	0	1,778
Expression profile of CTC and corresponding tumors in primary breast cancer patients Hopeful	05-19-2009 06:38 AM by Hopeful	0	1,785
trastuzumab-related cardiac dysfunction in the HERA Trial with 3.6 years follow- up Hopeful	05-19-2009 06:40 AM by Hopeful	0	1,806
trial of acupuncture for the management of AI associated joint symptoms Hopeful	05-19-2009 06:41 AM by Hopeful	0	1,627
Association between HER2/neu overexpression and calcifications in breast cancer Hopeful	05-20-2009 06:23 AM by Hopeful	0	1,628
Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy Hopeful	05-20-2009 06:26 AM by Hopeful	0	2,172
Risk factors associated with trastuzumab-associated cardiac toxicity Hopeful	05-20-2009 06:28 AM by Hopeful	0	1,775
HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer Hopeful	05-20-2009 06:30 AM by Hopeful	0	1,651
Long-term follow-up and factors of survival of HER-2 positive breast cancer patients Hopeful	05-20-2009 06:31 AM by Hopeful	0	1,749
Response to neoadjuvant chemotherapy and outcome based on breast cancer subtype Hopeful	05-20-2009 08:24 AM by bejuce	1	1,989
Trastuzumab cardiotoxicity: FDA review Hopeful	05-21-2009 06:44 AM by Hopeful	0	1,767
Sensitivity to endocrine therapy of PR+/ER- patients and ER+/PR- patients with HER2+ Hopeful	05-21-2009 06:46 AM by Hopeful	0	1,741
Weight gain after adjuvant TAC (docetaxel, doxorubicin, and cyclophosphamide) chemo Hopeful	05-21-2009 06:50 AM by Hopeful	0	2,092
Surgery vs primary endocrine therapy for elderly women Hopeful	05-21-2009 06:51 AM by Hopeful	0	1,667
Off-label drug use in women with breast cancer Hopeful	05-21-2009 06:59 AM by Hopeful	0	1,781
Pertuzumab monotherapy following trastuzumab-based treatment Hopeful	05-28-2009 12:39 AM by Rich66	1	1,272
Complications associated with erythropoietin stimulating agents in mbc patients Hopeful	05-22-2009 06:41 AM by Hopeful	0	1,461
Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in Hopeful	05-22-2009 06:44 AM by Hopeful	0	1,297
Characteristics of subsequent breast cancers in patients with benign breast disease Hopeful	06-01-2009 07:34 AM by Hopeful	0	1,095
What is the evidence for rechallenging with anthracyclines or taxanes in MBC? Hopeful	06-01-2009 07:39 AM by Hopeful	0	1,072
Differential timing and patterns of recurrence among breast cancer subtypes Hopeful	06-01-2009 07:40 AM by Hopeful	0	1,034
Impressive survival data with semimetronomic oral chemo Hopeful	06-02-2009 07:06 AM by Hopeful	0	954
Cardiac safety of the lapatinib/letrozole combination Hopeful	06-02-2009 07:08 AM by Hopeful	0	1,144
Concordant HER2 status between malignant CSF cells and primary breast carcinoma tissu Hopeful	06-02-2009 07:10 AM by Hopeful	0	1,074
Multifactorial CNS relapse susceptibility in HER2-positive breast cancer patients Hopeful	06-02-2009 07:12 AM by Hopeful	0	1,008
CA 125 in the early detection of metastatic breast cancer Hopeful	06-02-2009 07:15 AM by Hopeful	0	815
Detection of locally advanced breast cancer in the I-SPY TRIAL Hopeful	06-03-2009 06:34 AM by Hopeful	0	739
A study of lavender and tea tree oils on postmenopausal FSH levels and hot flash seve Hopeful	06-03-2009 07:26 PM by Laurel	1	1,176
Effect of simvastatin on the pharmacokinetics of anastrozole Hopeful	06-03-2009 06:38 AM by Hopeful	0	796
Evaluation of the effect of screening on the detection of good and poor prognosis bc Hopeful	06-04-2009 06:22 AM by Hopeful	0	842
Factors leading to the decision for contralateral prophylactic mastectomy Hopeful	06-04-2009 06:23 AM by Hopeful	0	876
Neuroprotective effect of SSRI among 781 cancer patients receiving chemotherapy Hopeful	06-04-2009 06:26 AM by Hopeful	0	895

Page 2 of 14

Last »

	New posts		Hot thread with new posts
	No new posts		Hot thread with no new posts
	Thread is closed

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 12:38 PM.